However, previous experimentations from other groups carried out on cultivated tumour cells of different origin have shown inhibitory effects of Resv on NFκB, AP-1, ERK, and IL-8 expression [2], [3], [7], [12], [66]–[68], [71]. The gene discussed is CXCL8; the disease is neoplasm.